financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Top Premarket Gainers
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top Premarket Gainers
Jun 17, 2024 5:17 AM

07:45 AM EDT, 06/17/2024 (MT Newswires) -- Scinai Immunotherapeutics ( SCNI ) shares surged 94% Monday premarket, extending Friday's rally.

The Aaron's Company (AAN) shares advanced 31% after the company agreed to a takeover offer from IQVentures.

Nurix Therapeutics ( NRIX ) shares were up 13% after the company said Sunday that patients responded well to its treatment candidate for non-Hodgkin lymphoma in a phase 1 trial.

VivoPower International ( VVPR ) shares rose 11% after Friday's 3.2% drop.

Price: 6.7600, Change: +3.27, Percent Change: +93.70

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
VF to Sell Supreme Brand to EssilorLuxottica for $1.5 Billion in Cash
VF to Sell Supreme Brand to EssilorLuxottica for $1.5 Billion in Cash
Jul 17, 2024
06:22 AM EDT, 07/17/2024 (MT Newswires) -- VF (VFC) said Wednesday that it entered into a definitive agreement to sell its Supreme brand to EssilorLuxottica for $1.5 billion in cash. The Supreme apparel and accessories brand runs a digital-first business and 17 stores in the US, Asia and Europe, the company said. The transaction is expected to close by the...
 Elevance Health beats quarterly profit estimates
Elevance Health beats quarterly profit estimates
Jul 17, 2024
(Reuters) - Elevance Health beat Wall Street estimates for quarterly profit on Wednesday, as the health insurer spent less than expected on the medical costs of its members. On an adjusted basis, the company reported a second-quarter profit of $10.12 per share, compared with analysts' estimates of $10.01 per share, according to LSEG data. (Reporting by Puyaan Singh and Sriparna...
 Adverum Reports Positive Interim Results in Study of Investigational Wet AMD Drug
Adverum Reports Positive Interim Results in Study of Investigational Wet AMD Drug
Jul 17, 2024
06:20 AM EDT, 07/17/2024 (MT Newswires) -- Adverum Biotechnologies ( ADVM ) said Wednesday that a 26-week interim analysis of its mid-stage trial of its novel gene therapy candidate, Ixo-vec, in patients with wet age-related macular degeneration showed the drug has a potential best-in-class product profile. Among two sets of 29 patients each receiving different dosages of Ixo-vec, patients needed...
 --Synchrony Financial Q2 Net Revenue Increases to $3.71 Billion From $3.29 Billion a Year Earlier
--Synchrony Financial Q2 Net Revenue Increases to $3.71 Billion From $3.29 Billion a Year Earlier
Jul 17, 2024
06:17 AM EDT, 07/17/2024 (MT Newswires) -- Price: 51.70, Change: -0.01, Percent Change: -0.02 ...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved